Hansoh Pharmaceutical Group Company Limited (stock code: 03692) published its Monthly Return for Equity Issuer for the period ended October 31, 2025, indicating stable figures in authorized and issued share capital. The authorized share capital remained 20,000,000,000 ordinary shares at HKD 0.00001 per share, totaling HKD 200,000. The number of issued shares was unchanged at 6,055,150,070.

According to the filing, zero coupon convertible bonds due 2026 carried a balance of USD 5,378,000 as of month-end. The conversion price stands at HKD 56.7 per share, potentially translating into 735,363 shares. No other modifications or movements in share capital, treasury shares, or share options were reported for the month.